Aalaa Sanad Abdallah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aalaa Sanad Abdallah has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Emilie K. Johnson
Division of Urology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, USA
2 shared publications - Emma Trasatti
Sex Development Clinic, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
2 shared publications - Jax Whitehead
Division of Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago , Chicago, IL 60611
2 shared publications - Xiao-Nan Li
Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, TX 77030, USA
2 shared publications Adam Davies
Sex Development Clinic, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
1 shared publication- Adam Davies
Sex Development Clinic, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA
1 shared publication
Latest Publications
- 30 July 2026
- Published by Elsevier in Cancer Letters
- Vol. 659
Therapy-associated lineage plasticity in DIPG following combined CDK4/6 inhibitor, temozolomide, and radiation
- 30 July 2026
- Published by Elsevier in Cancer Letters
- Vol. 659
Therapy-associated lineage plasticity in DIPG following combined CDK4/6 inhibitor, temozolomide, and radiation
- 12 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 894-902
Decision aid development for shared surgical decision-making in differences of sex development: A review of existing aids
- 12 April 2025
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 21 (4) , 894-902
Decision aid development for shared surgical decision-making in differences of sex development: A review of existing aids
- Open Access
Direct Implantation of Patient Brain Tumor Cells into Matching Locations in Mouse Brains for Patient-Derived Orthotopic Xenograft Model Development
Background: Despite multimodality therapies, the prognosis of patients with malignant brain tumors remains extremely poor. One of the major obstacles that hinders development of effective therapies is the limited availability of clinically relevant and biologically accurate (CRBA) mouse models. Methods: We have developed a freehand surgical technique that allows for rapid and safe injection of fresh human brain tumor specimens directly into the matching locations (cerebrum, cerebellum, or brainstem) in the brains of SCID mice. Results: Using this technique, we successfully developed 188 PDOX models from 408 brain tumor patient samples (both high-and low-grade) with a success rate of 72.3% in high-grade glioma, 64.2% in medulloblastoma, 50% in ATRT, 33.8% in ependymoma, and 11.6% in low-grade gliomas. Detailed characterization confirmed their replication of the histopathological and genetic abnormalities of the original patient tumors. Conclusions: The protocol is easy to follow, without a sterotactic frame, in order to generate large cohorts of tumor-bearing mice to meet the needs of biological studies and preclinical drug testing.
Open AccessDirect Implantation of Patient Brain Tumor Cells into Matching Locations in Mouse Brains for Patient-Derived Orthotopic Xenograft Model Development
Background: Despite multimodality therapies, the prognosis of patients with malignant brain tumors remains extremely poor. One of the major obstacles that hinders development of effective therapies is the limited availability of clinically relevant and biologically accurate (CRBA) mouse models. Methods: We have developed a freehand surgical technique that allows for rapid and safe injection of fresh human brain tumor specimens directly into the matching locations (cerebrum, cerebellum, or brainstem) in the brains of SCID mice. Results: Using this technique, we successfully developed 188 PDOX models from 408 brain tumor patient samples (both high-and low-grade) with a success rate of 72.3% in high-grade glioma, 64.2% in medulloblastoma, 50% in ATRT, 33.8% in ependymoma, and 11.6% in low-grade gliomas. Detailed characterization confirmed their replication of the histopathological and genetic abnormalities of the original patient tumors. Conclusions: The protocol is easy to follow, without a sterotactic frame, in order to generate large cohorts of tumor-bearing mice to meet the needs of biological studies and preclinical drug testing.